Mahamaya Lifesciences (BSE 544611)₹178.05−3.70%Pesticides & Agrochemicals
Mahamaya Lifesciences is compared with the 10 closest in size in Pesticides & Agrochemicals (34 companies in the industry). It has a P/E of 25.2 against a peer median of 17.0, and ROCE of 20.0% against a peer median of 11.0%. By market cap it is #8 of 11 in this set.
As of · Peer set: 10 closest in size in Pesticides & Agrochemicals
| Company | M-cap (₹ Cr) | P/E | ROCE % | ROE % | Debt / equity | Div. yield % | Sales (₹ Cr) | Net profit (₹ Cr) | Qtr sales growth % | Qtr profit growth % | Compare |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Astec LifeSciences | 1,176 | — | −5.0 | −25.3 | 1.16 | 0.0 | 447 | −81 | −2.7 | — | vs BSE 544611 |
| Punjab Chemicals & Crop Protection | 1,115 | 17.0 | 19.1 | 16.6 | 0.36 | 0.3 | 1,027 | 64 | 8.6 | 4.9 | vs BSE 544611 |
| Dharmaj Crop Guard | 811 | 13.5 | 16.0 | 13.1 | 0.29 | 0.0 | 1,138 | 55 | 4.1 | 15.1 | vs BSE 544611 |
| Advance Agrolife | 783 | 14.1 | 18.9 | 17.2 | 0.32 | 0.0 | 635 | 35 | 95.3 | 155.5 | vs BSE 544611 |
| Heranba Industries | 603 | — | −2.0 | −9.5 | 0.76 | 0.0 | 1,597 | −78 | −15.2 | 11.6 | vs BSE 544611 |
| Best Agrolife | 528 | 10.9 | 5.0 | 1.1 | 0.58 | 0.7 | 1,257 | 9 | −21.2 | 46.1 | vs BSE 544611 |
| Shivalik Rasayan | 488 | 35.9 | 5.0 | 2.1 | 0.19 | 0.2 | 368 | 18 | 7.8 | 59.8 | vs BSE 544611 |
| Mahamaya Lifesciences | 417 | 25.2 | 20.0 | 19.2 | 0.74 | 0.0 | 330 | 17 | — | — | — |
| Indogulf Cropsciences | 381 | 9.8 | 12.0 | 10.8 | 0.40 | 0.0 | 707 | 40 | −11.0 | −37.6 | vs BSE 544611 |
| Sikko Industries | 229 | 32.7 | 7.8 | 6.0 | 0.14 | 0.0 | 65 | 5 | −2.2 | 43.8 | vs BSE 544611 |
| Crop Life Science | 170 | 25.6 | 11.0 | 8.2 | 0.67 | 0.0 | 206 | 6 | −7.5 | 33.2 | vs BSE 544611 |
| Peer median | 528 | 17.0 | 11.0 | 8.2 | 0.40 | 0.0 | 635 | 17 | −2.4 | 33.2 |
Listed companies closest to Mahamaya Lifesciences in Pesticides & Agrochemicals include Astec LifeSciences, Punjab Chemicals & Crop Protection, Dharmaj Crop Guard, Advance Agrolife, Heranba Industries, Best Agrolife, Shivalik Rasayan, Indogulf Cropsciences.
Astec LifeSciences, with a market cap of ₹1,176 Cr.
Mahamaya Lifesciences trades at a P/E of 25.2; the median of its peer set is 17.0. A P/E above or below the median is a description, not a judgement on value.
Mahamaya Lifesciences' return on capital employed is 20.0%, above the peer median of 11.0%.